Pharm Exam#1

Download as pdf or txt
Download as pdf or txt
You are on page 1of 13

Thursday, December 5, 2013

Pharmacology Exam 1 Review


Introduction to Pharmacology

- Drug Usages
Diagnostics
- Glipizide: lowers blood sugar > diagnostics for DM
- Phentolamine and Phenoxybenzamine: diagnosis and treatment of
pheochromocytoma

Prevention, treatment, and cure


Placebo Effects
- Production of an effect independent of the chemical nature of the substance
Lactose capsules
- Pure placebo: lactose capsules or NaCl injection
- impure placebo: drug has another effect but not intended
ASA, B12, and Vitamin C
- Absorption
Weak acid: absorbed in the stomach
- anything with Sodium
Weak base: absorbed in the intestines
- anything with HCL or sulfate
Thiopental
- highly lipid soluble > CNS entrance
- rapidly redistribute through muscle and brain
Rapid onset of action and shortest duration of action
- Used as pre-anesthetic
Factors
- Depends on the physicochemical properties of molecule
pKa and pH
- Site of administration
1

Thursday, December 5, 2013

Injection gives 100%


- Formulation of drug
Liquid, elixirs, and syrups: Fastest
Tablets: slowest
- Food or fluids administered with the drug
Tetracycline with dairy products = inhibit absorption
Anti-fungal = enhance absorption
- Route
Enteral
- via mucosa and GI
- Oral, sublingual, buccal, and rectal
- Subjected to the First-Pass effect
drugs are subjected to the liver metabolism
IV can bypass the liver, thus preventing the metabolism
- IV, rectal, sublingual, Subcutaneous, transdermal, IM
- Rectal
Poor absorption surface
Parenteral
- IV, IM, SC,
IV is the fastest delivery into the blood circulation
Topical
- Skin, eyes, ears noses, and lungs
- Lidocaine and epinepherine
- Depo form = use solubility to delay absorption
- Benzethine + Penicillin G > Longer acting
- Distribution
Transport of a drug in the body by the blood stream to its site of action
protein-binding
- decreases bioavailability, but increases the duration of action
2

Thursday, December 5, 2013

Areas of rapid distribution: heart, liver, kidneys, and brain


Areas of slow distribution: muscle, skin, fat
Factors affecting distribution
- Lipophilicity:
- Drug molecule size
- protein binding
drug-drug interaction
- warfarin with Aspirin > rapid increase in warfarin = increase in bleeding
- rate of metabolism
- other binding sites
Blood Brain Barrier
- thiopental crosses BBB
- high lipid solubility = unable to cross BBB
- Metabolism
biological transformation of a drug into an inactive metabolite, a more soluble
compound, or a more potent metabolite

liver, kidney, lung, plasma, intestinal mucosa


factors deceasing metabolism:
- renal insufficiency
- CV dysfunction
- Slow acetylator
- Erythromycin and ketoconazole - Enzyme inhibitors
- Cimetidine
Factors that increase metabolism: Enzyme inducers
- Barbiturates - Phenobarbital
- Fast acetylators
- Rifampin
- carbamazepine
Effects
3

Thursday, December 5, 2013

- delayed drug metabolism: accumulation of drugs


prolonged action of the effects of the drugs
- Stimulation of drug metabolism
diminished pharmagologic effects
- Phase 1 reactions
Hydroxylation, oxidation, deamination, etc
- Phase 2 reactions
conjugation
Pro Drug
- the drug requires the activation by the liver
- Chloral Hydrate - Pro-drug
-> Triclorethanol = activated drug
Need Functional liver
- Excretion
ionized drugs: excreted in urine
Hyperuricemia:
- Probenecid binds to uric acid for excretion
Used with penicillin for effectiveness
Toxicity
- ASA or weak acid overdose = Sodium Bicarbonate
- Weak base Overdose = Vitamin C or ammonium chloride
Enterohepatic Cycling
Pseudocholinestersases - Deficiency > Paralysis
- Tolerance
decreasing response to repetitive drug doses
mechanism: enzyme induction
Bretylium: for tachyphalaxsis > rapid tolerance in 10mins
Adrenergic Agonists and Antagonist
4

Thursday, December 5, 2013

- NE = main NT
- multiple short pre-ganglionic to long post ganglionic nerves
- Adrenergic Agents: MOA
Direct Acting: binds directly to the receptor and causes physiologic response
Indirect acting: causes the release of catecholamine
Tyramine like effect
- MAOI with tyramine foods > hypertensive crisis
- Tyramine: by product of tyrosine metabolism
- Synthesis of NE
Tyrosine > L-DOPA > Dopamin > NE
Tyrosine Hydroxylase > Dopa Decraboxylase > Dopamine Beta-Hydroxylase
Cocaine = inhibits reuptake of NE = Sympathomimetic
Ampthetamine = increase NE release = Sympathomimetic
- Destruction of NE
Reuptake of NE
COMT - membrane bound enzyme
MAO -> pre-synaptic are of post ganglionic
Major Metabolite = VMA - excreted in urine
Guanethidine: inhibits secretion of NE = Sympatholytic
Reserpine = depletes NE at the storage granule = Sympatholytic
- Alpha 1 Receptors
Located on postsynaptic effector cells
Effects:
- Vasoconstriction and CNS stimulation
- GU: Constriction of Sphincter and Uterus Contraction
- Decreased insulin release
- Pupillary contraction via ciliary muscle contraction
Side Effects:
- CNS: Euphoria, excitement, insomnia
5

Thursday, December 5, 2013

- CV: palpitations, tachycardia, vasoconstriction


- Beta 1 Receptors
located in the heart
- Stimulation of heart
Effects:
- Heart
AV node = Increased heart rate
SA node = Increased heart rate
Increased force of contraction - Inotropic
Increased heart rate - chronotropic
Increased conduction through AV node - dromotropic
- Anorexiants:
Benzphetamine
Dextroamphetamine
Dexerdrine
- GI: Sphincter constriction
- Beta 2 receptors
located in smooth muscle of the bronchioles, arterioles, and visceral organs
- Relax smooth muscle = bronchodilation + Vasodilation + uterine relaxation
Effects:
- GI = decreased motility
- Bronchial Dilation
- Uterine relaxation
- Glycogenolysis = increase in beta
- Catecholamine Substitutions
- Methylation at the Amino group = increase in beta activity
NE : 95:5 > Epi: 50:50
- Alpha Blockers
Uses:
6

Thursday, December 5, 2013

- Vasodilation - reduction in BP
- decreased bladder contraction - BPH
- Pheochromocytoma
- Raynauds
Side Effects:
- CV: Palpitations, orthostatic Hypotension, tachycardia
- CNS: drowsiness, dizziness
- GI: constipation
- Incontinence
- Beta Blockers
Beta 1
- Decreased heart rate,
- slows conduction rate
- decreases myocardial oxygen demand
Beta 2
- Vasoconstriction, Bronchiole constriction
Uses:
- Anti-agina, cardioprotective, Glaucoma, hypertension,
Side Effects:
- bronchocontriction, bradycardia, hypoglycemia, rebound hypertension
Cholinergic Agonists and Antagonists

- Muscarinic Receptors
locations: Smooth muscles, cardiac muscle, glands
Simulation intestine and bladder
- Increased motility, secretion, and urinary frequency
Stimulate pupil
- Constriction and reduced intraocular pressure
Increased salivation and sweating
7

Thursday, December 5, 2013

Vasodilation and decreased heart rate


Bronchial Constriction
- At recommended doses: affects the muscarinic receptors
Higher doses: nicotinic Receptors
Muscarinic: desired effects
- Uses
Glaucoma
Bladder and GI motility increase
Alzheimers
- Side Effects:
Bradycardia, hypotension
headache
bronchospasms and increased bronchial secretions
- Cholinergic Antagonists
CV: Increase heart rate
CNS: drowsiness
EYE: pupil dilation + cycloplegia
GI: decreased muscle tone, peristalsis, and secretions
GU: increased constriction = retention
Bronchialdilation
- Side Effects
CV: increased HR
CNS: CNS excitation
Dilated pupils with cycloplegia
Urinary Retention
decreased bronchial secretion
Higher risk for heat stroke due to lack of sweating
- EYE
Glaucoma
8

Thursday, December 5, 2013

- Ciliary muscle contraction


cholinergic
- Decreased secretion
Beta-blockers
- Decreased secretion due to HCO inhibitor
diuretics
Eye dilation
- Atropine or cholinergic blockers = cause cycloplegia
- adrenergic drugs = NO cycloplegia
Bronchodilators

- Xanthine Derivatives
Theophylline
- Increases the levels of cAMP by inhibiting PDE > bronchodilation
- also causes CNS stimulation and cardiovascular stimulation
MILD TO Moderate asthma + COPD
SE:
- Nausea vomiting, GERD, tachycardia,
- Beta - agonists
sympathomimetics
Acute phase of asthmatic attacks
- quick dilation of bronchiole
Types
- Non-selective
Simulate both alpha and beta
Epinepherine
- Non-selective beta-adrenergics
both beta 1 and 2
Isoproterenol
9

Thursday, December 5, 2013

- Selective beta 2
albuterol
- loses specificity at larger doses
- Side Effects:
NS and B1+2
- cardiac stimulation
Albuterol
- tremor
- Anti-cholinergics
Prevention of brochoconstriction
slow and prolonged action: used for prevention of bronchospasm
SE: dry mouth, GI distress, and coughing
- Antileukotrienes
prevention of leukotrienes from attaching to receptors on cells
- prevention of inflammation
For: prophylaxis and chronic treatment of asthma
NOT for acute
SE: liver dysfunction
- Corticosteroids
Anti-inflammatory
Only for Chronic asthma
- do not relieve symptoms of acute asthmatic attacks
- Not considered as first-line agents
SE: pharyngeal irritation and fungal infections
- Mast cell stabilizers
Indirect-acting agents that prevents release of the various substances
ONLY for prophylaxis, Not for acute
Anti-hypertensive agents
10

Thursday, December 5, 2013

- Hypertension Classification
Normal: 130/85
High Normal: 130~139/85~89
Stage 1: 140-159/90~99
Stage 2:160-179/100~109
Stage 3: 180-209/110~119
Stage 4: 210/120
- Diuretics
Thiazide diuretics: HCTZ > early distal tubules
Potassium sparing diuretics > late distal tubules
- SE: hypokalemia
mild to moderate hypertension
Relative Indications:
- heart failure and systolic HTN
- Adrenergic Agents
Alpha 1 blockers
- SNS is not stimulated
- Uses:
BPH
severe CHF with diuretics
Centrally acting adrenergic
- alpha 2 agonists
- MODERATE TO SEVERE hypertension
- Uses:
hypertension
menopausal flushing, glaucoma
- Other indications:
heart failure, migraine, tachycardia, angina
Peripheral Acting Blockers
11

Thursday, December 5, 2013

- Inhibit release of NE or depletion of NE stores


- treatment of hypertension
- ACE inhibitors
used as FIRST LINE agents
-pril
Uses:
- Hypertension
- CHF
- slows the progression of left ventricular hypertrophy after an MI
Captopril +Trandolapril
- Renal protective effects in patients with diabetes
Ramipril + Captopril + Enalapril
SE:
- fatigue, dizziness
- coughing, due to bradykinin
Other indications
- DM, nephropathy, HF, previous MI
- A II Receptor Blockers
No coughing
-sartan
Uses:
- Hypertension
SE:
- headache, upper respiratory infection
- Calcium Channel Blockers
cause smooth muscle relaxation by blocking the binding of calcium to its receptors
USES:
- Angina, hypertension, Dysrhythmia, Migraine
SE:
12

Thursday, December 5, 2013

- Hypotension, palpitations, tachycardia


- Constipation
- rash and peripheral edema
other indications
- elderly systolic hypertension
- Vasodilators
may cause reflex tachycardia
beta blocker should be used prior
- Relative Indications
Elderly: dihydropyridine or diuretic, no beta blockers
African American: diuretics or Calcium channel blockers
1st line stage 1: ARB with HCTZ

13

You might also like